Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00002369

Public ClinicalTrials.gov record NCT00002369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Randomized, Comparative Study of Zerit (d4T) + Epivir (3TC) + Crixivan Versus Retrovir (AZT) + Epivir (3TC) + Crixivan in HIV-Infected, Antiretroviral Naive Subjects With CD4 Cell Counts of 200 - 700 Cells/mm3 and HIV RNA Baseline Copy Number of >= 10,000 Copies/ml

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.

Study identification

NCT ID
NCT00002369
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Oct 2, 2007

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294 —
HIV Clinical Research Ctr Fort Lauderdale Florida 33316 —
Infectious Disease Research Institute Inc Tampa Florida 33614 —
Advance Clinical Research Atlanta Georgia 30327 —
Louisiana State Univ Med Ctr / HIV Outpatient Clinic New Orleans Louisiana 70112 —
Boston Univ Med Ctr Hosp / Evans - 556 Boston Massachusetts 02118 —
Community Research Initiative of New England Brookline Massachusetts 02445 —
Washington Univ School of Medicine St Louis Missouri 63108 —
Blackstock Family Health Ctr Austin Texas 76751 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2007 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002369 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →